Health Rising

Visible At Last? Are Long COVID and ME/CFS Tissue Diseases? The PolyBio 2026 Symposium Pt I

PolyBio's 6th symposium was its best yet. In part one of a two-part series, we heard about their $10 million Long COVID Cure project, which they believe will cut 15 years off what would otherwise have been an interminably long search for treatments.

Then it was onto a series of presentations focusing on tissue studies (arteries, lymph, retina, gut, brainstem), which suggested that if you want to get to the heart of these diseases, you've got to go deep into the tissues.

Finally, we heard some good early news about two gut treatments that appear to be having an impact.

Health Rising Donation Drive Update

Thanks to everyone who's gotten us 2/3rds of the way there :)

Visible At Last? Are Long COVID and ME/CFS Tissue Diseases? The PolyBio 2026 Symposium Pt I - Health Rising Geoff’s Narration The GIST   The 2026 PolyBio Spring Symposium – Pt I One way to gauge the health of a field is by the number of conferences/symposia it supports. From the looks of things, the long–COVID and ME/CFS fields are moving up: The International ME/CFS conference – May 7-8 […]

Hitting the Target? ME/CFS and long COVID T-Cell Researchers on Uncovering the Precise Drivers of the Illnesses

Researchers are increasingly confident that precision medicine - the ability to match a treatment to your biology - is coming for these diseases.

T-cell researchers are at the top of that list. Not only are they now sure that these diseases are driven by pathogens/autoimmune processes, but they've also begun using sophisticated technologies they believe will allow them to uncover the precise drivers of these illnesses.

Find out more

Hitting the Target? ME/CFS and long COVID T-Cell Researchers on Uncovering the Precise Drivers of the Illnesses - Health Rising Dr. Selin and company believe they can solve one of the key mysteries of ME/CFS and long COVID: exactly why the T-cells are getting pummeled.

A Novel Immunomodulatory Strategy for ME/CFS + A Paradox Resolved?

Last year, a researcher called this pathway the "dominant metabolic pathway" in ME/CFS.

This year, an Open Medicine Foundation study uncovered a problem in it that could leave the cells in ME/CFS "inert and unresponsive".

Not only that, but this problem could potentially explain a paradox that has bedeviled the ME/CFS field for over a decade.

That's pretty good stuff, but the icing on the cake is that the Open Medicine Foundation is using a "novel immunodulatory strategy" in their new clinical trials program to see if they can fix the problem.

Things are moving fast. It all goes to show that you never know what's going to pop up. Check it out.

A Novel Immunomodulatory Strategy for ME/CFS + A Paradox Resolved? - Health Rising A novel immunomodulatory treatment approach to ME/CFS appears and a paradox could be resolved....

Takeaways From the Big Long COVID Clinical Trials

A good number of long COVID clinical trials have been done, and more are on the way, but only ten "Tier 1" trials - trials large enough for us to trust their results - have been published.

Two were modest successes, and the rest bombed. That didn't prevent them from giving us more clues about what will work in long COVID, though.

Check out the two "winners" and what we've learned in

Takeaways From the Big Long COVID Clinical Trials - Health Rising Only 10 major long COVID clinical trials have been published thus far but that's enough to come away with some interesting takeaways. They include treatments that prevent long COVID don't necessarily treat it, broader based treatments are probably best, manipulating the gut can help with fatigue (bu...